{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:29:44Z","timestamp":1795073384341,"version":"4.10.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017539","name":"Theodor Bilharz Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017539","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the pathophysiology is still not fully understood. Recent evidence suggests that the gut microbiota may play a role in the pathophysiology of NAFLD and may also offer new therapeutic options.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective cross-sectional study included 100 consecutive newly diagnosed obese patients (BMI\u2009\u2265\u200995th percentile), aged 14\u201318 years with NAFLD (confirmed by ultrasound), persistently elevated levels of alanine aminotransferase (ALT) greater than 60 U\/L for 1\u20136 months, and 100 healthy controls. We evaluated changes in the gut microbiota in NAFLD adolescents compared with healthy controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>According to the multiple logistic regressions, the variables associated with NAFLD were the presence of Clostridium difficile, the presence of Salmonella spp., a greater abundance of Bifidobacterium and Prevotella, and a lower abundance of Lactobacillus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Changes in the gut microbiota occur in adolescents with NAFLD compared with healthy individuals, which may be useful for identifying youths who are amenable to gut microbiota-based interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial number<\/jats:title>\n                <jats:p>Not applicable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-024-05268-y","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:13:11Z","timestamp":1732849991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?"],"prefix":"10.1186","volume":"24","author":[{"given":"Doaa El","family":"Amrousy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba El","family":"Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"3","key":"5268_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","volume":"69","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2019-318813.","journal-title":"Gut"},{"issue":"11","key":"5268_CR2","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, Vipani A, Bresee C, et al. NASH Leading cause of Liver Transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649\u201359. https:\/\/doi.org\/10.1038\/s41395-018-0088-6.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5268_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"4","key":"5268_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388\u201393. https:\/\/doi.org\/10.1542\/peds.2006-1212.","journal-title":"Pediatrics"},{"key":"5268_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jpeds.2018.04.047","volume":"200","author":"DM Fernandes","year":"2018","unstructured":"Fernandes DM, Pantangi V, Azam M, et al. Pediatric nonalcoholic fatty liver disease in New York City: an autopsy study. J Pediatr. 2018;200:174\u201380. https:\/\/doi.org\/10.1016\/j.jpeds.2018.04.047.","journal-title":"J Pediatr"},{"issue":"6","key":"5268_CR6","doi-asserted-by":"publisher","first-page":"e20200771","DOI":"10.1542\/peds.2020-0771","volume":"146","author":"AK Sahota","year":"2020","unstructured":"Sahota AK, Shapiro WL, Newton KP, Kim ST, Chung J, Schwimmer JB. Incidence of nonalcoholic fatty liver disease in children: 2009\u20132018. Pediatrics. 2020;146(6):e20200771. https:\/\/doi.org\/10.1542\/peds.2020-0771.","journal-title":"Pediatrics"},{"issue":"5","key":"5268_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/0009922817733300","volume":"57","author":"AE Ferguson","year":"2018","unstructured":"Ferguson AE, Xanthakos SA, Siegel RM. Challenges in Screening for Pediatric nonalcoholic fatty liver disease. Clin Pediatr (Phila). 2018;57(5):558\u201362. https:\/\/doi.org\/10.1177\/0009922817733300.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"5268_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF. Steatohepatitis: a tale of two hits? Gastroenterology. 1998;114(4):842\u20135. https:\/\/doi.org\/10.1016\/s0016-5085(98)70599-2.","journal-title":"Gastroenterology"},{"issue":"7164","key":"5268_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804\u201310. https:\/\/doi.org\/10.1038\/nature06244.","journal-title":"Nature"},{"issue":"7402","key":"5268_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207\u201314. https:\/\/doi.org\/10.1038\/nature11234. Published 2012 Jun 13.","journal-title":"Nature"},{"issue":"5","key":"5268_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease [published correction appears in nat Rev Immunol. 2009;9(8):600]. Nat Rev Immunol. 2009;9(5):313\u201323. https:\/\/doi.org\/10.1038\/nri2515.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5268_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"5268_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.chom.2020.07.014","volume":"28","author":"B McDonald","year":"2020","unstructured":"McDonald B, Zucoloto AZ, Yu IL, et al. Programing of an Intravascular Immune Firewall by the gut microbiota protects against Pathogen dissemination during infection. Cell Host Microbe. 2020;28(5):660\u2013e6684. https:\/\/doi.org\/10.1016\/j.chom.2020.07.014.","journal-title":"Cell Host Microbe"},{"issue":"237","key":"5268_CR14","doi-asserted-by":"publisher","first-page":"237ra66","DOI":"10.1126\/scitranslmed.3008618","volume":"6","author":"ML Balmer","year":"2014","unstructured":"Balmer ML, Slack E, de Gottardi A, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6(237):237ra66. https:\/\/doi.org\/10.1126\/scitranslmed.3008618.","journal-title":"Sci Transl Med"},{"key":"5268_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pathol-030320-095722","volume":"16","author":"RM Jones","year":"2021","unstructured":"Jones RM, Neish AS. Gut microbiota in Intestinal and Liver Disease. Annu Rev Pathol. 2021;16:251\u201375. https:\/\/doi.org\/10.1146\/annurev-pathol-030320-095722.","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"5268_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139. https:\/\/doi.org\/10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"2","key":"5268_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","volume":"53","author":"A Shannon","year":"2011","unstructured":"Shannon A, Alkhouri N, Carter-Kent C, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J Pediatr Gastroenterol Nutr. 2011;53(2):190\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e31821b4b61.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"5268_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jped.2017.09.003","volume":"94","author":"CS Mello","year":"2018","unstructured":"Mello CS, Rodrigues MSDC, Filho HBA, et al. Fecal microbiota analysis of children with small intestinal bacterial overgrowth among residents of an urban slum in Brazil. J Pediatr (Rio J). 2018;94(5):483\u201390. https:\/\/doi.org\/10.1016\/j.jped.2017.09.003.","journal-title":"J Pediatr (Rio J)"},{"issue":"11","key":"5268_CR19","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1128\/JCM.01360-10","volume":"48","author":"R Verma","year":"2010","unstructured":"Verma R, Verma AK, Ahuja V, Paul J. Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol. 2010;48(11):4279\u201382. https:\/\/doi.org\/10.1128\/JCM.01360-10.","journal-title":"J Clin Microbiol"},{"key":"5268_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12038-023-00387-7","volume":"49","author":"DE Amrousy","year":"2024","unstructured":"Amrousy DE, Ashry HE, Maher S, Abdelhai D, Hassan S. Helicobacter pylori infection and gut microbiota in adolescists: Is there a relation? J Biosci. 2024;49:7.","journal-title":"J Biosci"},{"key":"5268_CR21","doi-asserted-by":"publisher","first-page":"597966","DOI":"10.3389\/fimmu.2020.597966","volume":"11","author":"WH Wu","year":"2020","unstructured":"Wu WH, Zegarra-Ruiz DF, Diehl GE. Intestinal microbes in Autoimmune and Inflammatory Disease. Front Immunol. 2020;11:597966. https:\/\/doi.org\/10.3389\/fimmu.2020.597966. Published 2020 Dec 23.","journal-title":"Front Immunol"},{"key":"5268_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-12-394300-2.00003-X","volume":"116","author":"B Chassaing","year":"2012","unstructured":"Chassaing B, Aitken JD, Gewirtz AT, Vijay-Kumar M. Gut microbiota drives metabolic disease in immunologically altered mice. Adv Immunol. 2012;116:93\u2013112. https:\/\/doi.org\/10.1016\/B978-0-12-394300-2.00003-X.","journal-title":"Adv Immunol"},{"issue":"27","key":"5268_CR23","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of Inflammatory Bowel diseases. N Engl J Med. 2020;383(27):2652\u201364. https:\/\/doi.org\/10.1056\/NEJMra2002697.","journal-title":"N Engl J Med"},{"issue":"7","key":"5268_CR24","doi-asserted-by":"publisher","first-page":"e3043","DOI":"10.1002\/dmrr.3043","volume":"34","author":"P Zheng","year":"2018","unstructured":"Zheng P, Li Z, Zhou Z. Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev. 2018;34(7):e3043. https:\/\/doi.org\/10.1002\/dmrr.3043.","journal-title":"Diabetes Metab Res Rev"},{"key":"5268_CR25","doi-asserted-by":"publisher","unstructured":"Koteish A, Mae Diehl A. Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16(5):679\u2009\u2013\u200990. https:\/\/doi.org\/10.1053\/bega.2002.0332. PMID: 12406439.","DOI":"10.1053\/bega.2002.0332"},{"issue":"44","key":"5268_CR26","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718\u201323. https:\/\/doi.org\/10.1073\/pnas.0407076101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7800","key":"5268_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","volume":"579","author":"S Zhao","year":"2020","unstructured":"Zhao S, Jang C, Liu J, et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature. 2020;579(7800):586\u201391. https:\/\/doi.org\/10.1038\/s41586-020-2101-7.","journal-title":"Nature"},{"issue":"4","key":"5268_CR28","first-page":"245","volume":"29","author":"S Zakhari","year":"2006","unstructured":"Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health. 2006;29(4):245\u201354.","journal-title":"Alcohol Res Health"},{"issue":"2","key":"5268_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601\u20139. https:\/\/doi.org\/10.1002\/hep.26093.","journal-title":"Hepatology"},{"issue":"2","key":"5268_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsec\/fiu002","volume":"91","author":"S Michail","year":"2015","unstructured":"Michail S, Lin M, Frey MR, et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol Ecol. 2015;91(2):1\u20139. https:\/\/doi.org\/10.1093\/femsec\/fiu002.","journal-title":"FEMS Microbiol Ecol"},{"issue":"2","key":"5268_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","volume":"65","author":"F Del Chierico","year":"2017","unstructured":"Del Chierico F, Nobili V, Vernocchi P, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65(2):451\u201364. https:\/\/doi.org\/10.1002\/hep.28572.","journal-title":"Hepatology"},{"issue":"4","key":"5268_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","volume":"157","author":"JB Schwimmer","year":"2019","unstructured":"Schwimmer JB, Johnson JS, Angeles JE, et al. Microbiome signatures Associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease. Gastroenterology. 2019;157(4):1109\u201322. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.028.","journal-title":"Gastroenterology"},{"issue":"1","key":"5268_CR33","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1038\/s41598-020-59535-w","volume":"10","author":"TS Dong","year":"2020","unstructured":"Dong TS, Katzka W, Lagishetty V, Luu K, Hauer M, Pisegna J, Jacobs JP. A Microbial signature identifies Advanced Fibrosis in patients with chronic liver Disease mainly due to NAFLD. Sci Rep. 2020;10(1):2771. https:\/\/doi.org\/10.1038\/s41598-020-59535-w. PMID: 32066758; PMCID: PMC7026172.","journal-title":"Sci Rep"},{"issue":"3","key":"5268_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.chom.2019.01.004","volume":"25","author":"F De Filippis","year":"2019","unstructured":"De Filippis F, Pasolli E, Tett A, Tarallo S, Naccarati A, De Angelis M, Neviani E, Cocolin L, Gobbetti M, Segata N, Ercolini D. Distinct genetic and functional traits of human intestinal Prevotella copri strains are Associated with different habitual diets. Cell Host Microbe. 2019;25(3):444\u2013e4533. Epub 2019 Feb 21. PMID: 30799264.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"5268_CR35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.chom.2019.10.013","volume":"26","author":"H Fehlner-Peach","year":"2019","unstructured":"Fehlner-Peach H, Magnabosco C, Raghavan V, et al. Distinct polysaccharide utilization profiles of human intestinal Prevotella copri isolates. Cell Host Microbe. 2019;26(5):680\u2013e6905. https:\/\/doi.org\/10.1016\/j.chom.2019.10.013.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"5268_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.chom.2019.08.018","volume":"26","author":"A Tett","year":"2019","unstructured":"Tett A, Huang KD, Asnicar F, et al. The Prevotella copri Complex comprises four distinct clades underrepresented in westernized populations. Cell Host Microbe. 2019;26(5):666\u2013e6797. https:\/\/doi.org\/10.1016\/j.chom.2019.08.018.","journal-title":"Cell Host Microbe"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05268-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:42:03Z","timestamp":1732855323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05268-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05268-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee of the Faculty of Medicine, Tanta University, approved the study. The study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents of all the subjects of the study before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors had access to the study data and reviewed and approved the final manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Access to study data"}}],"article-number":"779"}}